© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Joseph Alvarnas, MD
Articles
From the Editor-in-Chief: Shiny New Objects Within a Struggling System
August 18, 2021
Article
"No matter where you go, there you are." Buckaroo Banzai
Flying the Plane While You Build It
February 16, 2021
Article
In this issue of Evidence-Based Oncology™ we see a foreshadowing of what the future of cancer care innovation could look like and how we may learn to move forward, safely, at an ever-accelerating pace.
Employers: Innovators and Partners in the Delivery of More Effective and Equitable Cancer Care
December 24, 2020
Article
Employers have the focus, innovative mindset, analytical tools, and drive to partner effectively with innovative cancer care entities to bring better care to their respective members.
Where Myths Go to Die
August 17, 2020
Article
From the Editor-in-Chief, Evidence-Based Oncology, August 2020.
From the Editor-in-Chief: Bigger Questions of Systems, Viruses, and the Lives of Real People
June 19, 2020
Article
As I recall the early days of the HIV/AIDS pandemic, what stands out most is its profound human cost and the courage of those who helped our society transcend it. We are in the midst of a time in which the human toll of COVID-19 and the enormity of the path ahead are clear.
References for Humility and Hope, Alvarnas
June 19, 2020
Article
References: Humility and Hope: Evolution of the HIV Pandemic, From ART to Today’s Cancer Cures
Humility and Hope: Evolution of the HIV Pandemic, From ART to Today's Cancer Cures
June 19, 2020
Article
The connections between cancer and HIV/AIDS became clear relatively early in the HIV/AIDS pandemic and continue to this day. Not only were opportunistic infections present in a majority of HIV-infected patients who met the initial diagnostic criteria for AIDS, but several cancer types were far more prevalent as well. While there is still much to understand before HIV is fully conquered, we have already learned a great deal about the pathobiology of this virus that has helped advanced immune-oncological technologies and led to the development of increasingly effective gene therapy delivery systems.